Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HR Stock Summary
Top 10 Correlated ETFs
HR
In the News

Healthcare Realty Rolls Out $500M Share Repurchase - Buyback Wednesdays
Healthcare Realty is the largest pure play Medical Office Buildings (MOB) REIT in the United States. The REIT has a forward dividend yield of 6.6% and is well-covered by a 75% payout ratio. With the stock down more than 30% over the last year, we saw insider buying in March and now the company wants to opportunistically buy back shares.

Healthcare Realty: A Sane 7%-Yielding Bargain Not To Miss
Healthcare Realty, a REIT focused on medical office buildings, offers a high dividend yield of 6.7% and is well-covered by a 78% FFO payout ratio. The company benefits from the shift of patient care from hospitals to outpatient settings, with estimates forecasting outpatient demand for those aged 55+ to grow by 2025. Despite some risks such as higher interest rates and elevated leverage, Healthcare Realty's share price appears to be a bargain, offering income investors a quality asset base.

Sell Alert: 2 REITs Getting Risky
I am bullish on some REITs, but not all of them. Some REITs are overpriced. Others are risky. We highlight two REITs that we have sold in recent years.

H&R REIT: Possibly The Only Office Bet You Should Consider
We moved to the sidelines on our last update on H&R REIT. The timing was good and the REIT succumbed to broader sector pressures.

Healthcare Realty Trust (HR) Lags Q1 FFO and Revenue Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.40 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to FFO of $0.44 per share a year ago.

Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call
NASHVILLE, Tenn., April 19, 2023 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that it expects to report results for the first quarter of 2023 on Tuesday morning, May 9, 2023, before the market opens.

How Much Upside is Left in Healthcare Realty Trust (HR)? Wall Street Analysts Think 34.48%
The mean of analysts' price targets for Healthcare Realty Trust (HR) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Medical Properties Trust Vs. Healthcare Realty: One Has A 14.3% Yield That I'm Buying
Medical Properties offers a dividend yield that is 790 basis points higher than peer REIT Healthcare Realty. This has been driven by common shares down 62% over the last year. This dichotomy is fundamentally driven by angst around a potential Medical Properties dividend cut, with Healthcare Realty's yield also being driven higher in recent months.

2 Dividends To Never Have To Work Again
One major worry for retirees is running out of money. It's a true but scary fact that most retirees see a massive income cut when they retire.

Should You Buy Healthcare Realty Trust for Its 6.5% Yield?
Healthcare Realty posted a loss in its most recent quarterly results, but that doesn't mean its dividend is in trouble. Analysts are expecting a better year from the company, and the stock's low valuation may even make it a cheap buy.
HR Financial details
HR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 3.38 | 3.67 | 3.73 | 3.75 | 3.6 | |
Net income per share | 1.04 | 0.44 | 0.88 | -0.18 | -0.42 | |
Operating cash flow per share | 1.64 | 1.67 | 3.51 | 1.63 | 1.08 | |
Free cash flow per share | 1.26 | 1.16 | 2.81 | 0.93 | 1.08 | |
Cash per share | 0.61 | 0.01 | 0.11 | 0.09 | 0.72 | |
Book value per share | 15.8 | 14.84 | 14.55 | 15.32 | 30 | |
Tangible book value per share | 12.79 | 14.79 | 14.55 | 15.25 | 25.31 | |
Share holders equity per share | 15.8 | 14.84 | 14.55 | 15.32 | 30 | |
Interest debt per share | 12.83 | 14.63 | 13.2 | 15.31 | 3.09 | |
Market cap | 5.86B | 4.27B | 3.96B | 4.51B | 4.86B | |
Enterprise value | 8.28B | 5.79B | 5.66B | 6.42B | 5.15B | |
P/E ratio | 27.45 | 75.03 | 33.46 | -172.89 | -45.97 | |
Price to sales ratio | 8.42 | 9.08 | 7.93 | 8.44 | 5.36 | |
POCF ratio | 17.37 | 20.04 | 8.43 | 19.4 | 17.83 | |
PFCF ratio | 22.58 | 28.77 | 10.54 | 34.21 | 17.83 | |
P/B Ratio | 1.8 | 2.25 | 2.03 | 2.07 | 0.64 | |
PTB ratio | 1.8 | 2.25 | 2.03 | 2.07 | 0.64 | |
EV to sales | 11.89 | 12.32 | 11.33 | 12 | 5.68 | |
Enterprise value over EBITDA | 14.1 | 22.68 | 20.65 | 22.32 | 8 | |
EV to operating cash flow | 24.53 | 27.19 | 12.05 | 27.6 | 18.9 | |
EV to free cash flow | 31.89 | 39.03 | 15.06 | 48.66 | 18.9 | |
Earnings yield | 0.04 | 0.01 | 0.03 | -0.01 | -0.02 | |
Free cash flow yield | 0.04 | 0.03 | 0.09 | 0.03 | 0.06 | |
Debt to equity | 0.88 | 0.88 | 0.96 | 0.95 | 0.81 | |
Debt to assets | 0.46 | 0.47 | 0.49 | 0.49 | 0.45 | |
Net debt to EBITDA | 4.12 | 5.96 | 6.2 | 6.63 | 0.45 | |
Current ratio | 1.72 | 0.01 | 0.44 | 0.15 | 0.85 | |
Interest coverage | 1.58 | 1.38 | 1.48 | 1.6 | 1.28 | |
Income quality | 1.58 | 5.44 | 6.51 | 3.49 | 6.7 | |
Dividend Yield | 0.04 | 0.04 | 0.04 | 0.04 | 0.24 | |
Payout ratio | 1.18 | 2.73 | 1.37 | -6.72 | -10.96 | |
Sales general and administrative to revenue | 0.05 | 0.07 | 0.06 | 0.06 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.11 | 0 | 0 | 0 | 0.09 | |
Capex to operating cash flow | 0.75 | -0.3 | -0.2 | -0.43 | 0 | |
Capex to revenue | 0.36 | -0.14 | -0.19 | -0.19 | 0 | |
Capex to depreciation | 0.93 | -0.36 | -0.48 | -0.49 | 0 | |
Stock based compensation to revenue | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | |
Graham number | 19.19 | 12.19 | 17.02 | 7.94 | 16.82 | |
ROIC | 0.03 | 0.03 | 0.03 | -0.01 | -0.04 | |
Return on tangible assets | 0.04 | 0.02 | 0.03 | -0.01 | -0.01 | |
Graham Net | -12.79 | -12.5 | -13.8 | -14 | -23.37 | |
Working capital | 133.98M | -77.97M | -46.44M | -73.17M | -51.4M | |
Tangible asset value | 2.64B | 1.89B | 1.95B | 2.18B | 6.39B | |
Net current asset value | -2.53B | -1.66B | -1.83B | -2.06B | -5.87B | |
Invested capital | 0.78 | 0.96 | 0.88 | 0.97 | 0.08 | |
Average receivables | 119.18M | 103.57M | 41.75M | 42.45M | 102.57M | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 64.84 | 64.8 | 0 | 57.94 | 48.36 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 5.63 | 5.63 | 0 | 6.3 | 7.55 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.07 | 0.03 | 0.06 | -0.01 | -0.01 | |
Capex per share | 1.23 | -0.51 | -0.7 | -0.71 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.96 | 0.97 | 0.93 | 1.04 | 0.88 | |
Net income per share | 0.12 | -0.05 | -0.07 | -0.27 | -0.32 | |
Operating cash flow per share | 0.29 | 0.47 | 0.04 | 0.3 | 0.18 | |
Free cash flow per share | 0.14 | 0.32 | -0.12 | 0.71 | 0.02 | |
Cash per share | 0.15 | 0.23 | 0.54 | 0.72 | 0.13 | |
Book value per share | 14.86 | 14.55 | 23.5 | 30 | 19.42 | |
Tangible book value per share | 12.14 | -15.23 | 23.12 | 25.31 | 18.79 | |
Share holders equity per share | 14.86 | 14.55 | 23.5 | 30 | 19.42 | |
Interest debt per share | 13.94 | 14.93 | 18.13 | 2.73 | 17.72 | |
Market cap | 4.09B | 4.07B | 6.86B | 4.86B | 7.32B | |
Enterprise value | 6.13B | 6.26B | 12.71B | 5.15B | 12.99B | |
P/E ratio | 55.96 | -126.2 | -70.16 | -17.95 | -14.92 | |
Price to sales ratio | 28.65 | 28.01 | 22.38 | 18.62 | 22 | |
POCF ratio | 93.52 | 57.87 | 546.78 | 64.21 | 105.84 | |
PFCF ratio | 200.22 | 84.74 | -173 | 27.2 | 810.87 | |
P/B Ratio | 1.85 | 1.87 | 0.89 | 0.64 | 1 | |
PTB ratio | 1.85 | 1.87 | 0.89 | 0.64 | 1 | |
EV to sales | 42.93 | 43.06 | 41.49 | 19.74 | 39.01 | |
Enterprise value over EBITDA | 82.63 | 80.76 | 69.08 | 29.8 | 66.36 | |
EV to operating cash flow | 140.15 | 88.95 | 1.01K | 68.06 | 187.71 | |
EV to free cash flow | 300.05 | 130.24 | -320.72 | 28.83 | 1.44K | |
Earnings yield | 0 | 0 | 0 | -0.01 | -0.02 | |
Free cash flow yield | 0 | 0.01 | -0.01 | 0.04 | 0 | |
Debt to equity | 0.99 | 1.09 | 0.82 | 0.81 | 0.83 | |
Debt to assets | 0.5 | 0.52 | 0.45 | 0.45 | 0.45 | |
Net debt to EBITDA | 27.49 | 28.22 | 31.82 | 1.69 | 28.94 | |
Current ratio | 0.09 | 0.06 | 1.07 | 0.85 | 0.34 | |
Interest coverage | 1.49 | 1.43 | 0.34 | 0.79 | 0.18 | |
Income quality | 1.04 | 11.48 | 0.44 | -1.79 | -0.79 | |
Dividend Yield | 0.01 | 0.01 | 0.17 | 0.01 | 0.02 | |
Payout ratio | 2.56 | -5.83 | -48.94 | -0.54 | -0.96 | |
Sales general and administrative to revenue | 0.08 | 0.07 | 0.05 | 0.05 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.98 | 0.02 | 0.09 | 0.03 | |
Capex to operating cash flow | -0.53 | -0.32 | -4.16 | 1.36 | -0.87 | |
Capex to revenue | -0.16 | -0.15 | -0.17 | 0.39 | -0.18 | |
Capex to depreciation | -0.42 | -0.39 | -0.31 | 0.8 | -0.31 | |
Stock based compensation to revenue | 0.03 | 0.02 | 0.03 | 0 | 0.01 | |
Graham number | 6.41 | 4.2 | 6.27 | 13.46 | 11.9 | |
ROIC | 0 | -0.01 | 0 | 0.02 | 0 | |
Return on tangible assets | 0 | -0.09 | 0 | -0.01 | -0.01 | |
Graham Net | -14.6 | -15.61 | -18.34 | -23.37 | -15.38 | |
Working capital | -366.16M | -540.4M | 35.21M | -51.4M | -101.97M | |
Tangible asset value | 1.81B | -2.28B | 7.6B | 6.39B | 7.12B | |
Net current asset value | -2.16B | -2.34B | -5.83B | -5.87B | -6.05B | |
Invested capital | 0.93 | 1.02 | 0.77 | 0.08 | 0.9 | |
Average receivables | 42.45M | 0 | 100.22M | 160.34M | 210.56M | |
Average payables | 0 | 0 | 652K | 652K | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 58.88 | 41.43 | 81.34 | |
Days payables outstanding | 0 | 0 | 1.04 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 1.53 | 2.17 | 1.11 | |
Payables turnover | 0 | 0 | 86.25 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0 | 0 | -0.01 | -0.02 | |
Capex per share | -0.16 | -0.15 | -0.16 | 0.41 | -0.16 |
HR Frequently Asked Questions
What is Healthcare Realty Trust Incorporated stock symbol ?
Healthcare Realty Trust Incorporated is a US stock , located in Nashville of Tn and trading under the symbol HR
Is Healthcare Realty Trust Incorporated buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $21. The lowest prediction is $20 and the highest is $22
What is HR stock prediction ?
What is Healthcare Realty Trust Incorporated stock quote today ?
Healthcare Realty Trust Incorporated stock price is $19.69 today.
Is Healthcare Realty Trust Incorporated stock public?
Yes, Healthcare Realty Trust Incorporated is a publicly traded company.